Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CHSCP will rise by +6.30% over the next 2 Weeks and hit $29.70 by Friday, November 24, 2023. In that time frame, CHSCP's share price is expected to range between $29.42 and $29.98.
BearishAverageBullishCHSCP shares fell -0.61% in Wednesday, December 24, 2025's trading session, dropping from a previous close of $27.94 to move at $27.77. The stock demonstrated notable intraday movement (see CHSCP's key stats for a full breakdown), fluctuating between $27.76 and $27.96, a +0.72% trading range. While recent weeks have seen some volatility, CHSCP has managed to secure a -1.80% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 5.78K shares changing hands, 1.37K fewer than the previous session. This amounted to $160.54K in total market activity.
Will CHSCP Continue Its Upward Trend?
According to analyst ratings and projections for CHSCP, CHS Inc. shares are anticipated to increase by +7.37%, potentially reaching $29.98 per share by November 24, 2023. Short-term technical indicators currently suggest a neutral sentiment for CHSCP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the CHSCP stock forecast, now is a good time to buy CHSCP stock because its current trading price is -6.50% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CHSCP covering social and institutional perspectives.
CHSCP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CHSCP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.82% to 45.42%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.40%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.79%, maintains a neutral outlook for the long term. Insights into CHSCP's shareholder base show how institutional investors are positioning themselves during these momentum shifts

